(Q24295018)

GOA release 2020-03-11

fatty acid binding

1 reference

A general, wide-rage spectrofluorometric method for measuring the site-specific affinities of drugs toward human serum albumin

GOA release 2020-03-11

author name string

Ronald W Sarver

series ordinal

1

0 references

Hua Gao

series ordinal

2

0 references

Fang Tian

series ordinal

3

0 references

language of work or name

English

0 references

publication date

15 December 2005

0 references

published in

Analytical Biochemistry

0 references

volume

347

0 references

page(s)

297-302

0 references

issue

2

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Characterization of site I on human serum albumin: concept about the structure of a drug binding site.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Predicting plasma protein binding of drugs: a new approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Interactive binding to the two principal ligand binding sites of human serum albumin: effect of the neutral-to-base transition

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Fluorine-19 NMR spin-spin relaxation (T2) method for characterizing volatile anesthetic binding to proteins. Analysis of isoflurane binding to serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Rational design of diflunisal analogues with reduced affinity for human serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Atomic structure and chemistry of human serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Interactions of myristic acid with bovine serum albumin: a 13C NMR study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Palmitate and stearate binding to human serum albumin. Determination of relative binding constants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Spectroscopic techniques in the study of protein binding. A fluorescence technique for the evaluation of the albumin binding and displacement of warfarin and warfarin-alcohol

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Determination of the affinity of drugs toward serum albumin by measurement of the quenching of the intrinsic tryptophan fluorescence of the protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Practical aspects of the ligand-binding and enzymatic properties of human serum albumin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021

Competition binding experiments for rapidly ranking lead molecules for their binding affinity to human serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2005.09.039

7 January 2021